NCT02056392 2015-11-09To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male VolunteersAstraZenecaPhase 1 Completed54 enrolled 31 charts
NCT01017731 2015-06-10Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval ChangesEli Lilly and CompanyPhase 2 Completed68 enrolled 13 charts